Document is current

Article History

Received: 16 August 2025

Revised: 13 March 2026

Accepted: 9 April 2026

First Online: 18 April 2026

Competing interests

: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: PS reports a relationship with Roche, Thermo Fisher, bioMérieux, Nestlé Health Science and Abbott Nutrition. that includes: funding grants. ZS reports a relationship with Nestlé Health Science, Fresenius Kabi and B. Braun that includes: funding grants. If there are other authors, they declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

: During the preparation of this work the authors used OpenAI. (2024). ChatGPT (Version 4) to improve the writing and English language quality of their manuscript. After using this tool, the authors reviewed and edited the content as needed and take full responsibility for the content of the publication.

: The Ethics Committee of Northwestern/Central Switzerland (EKNZ; 2014_001) approved the study protocol. All participants or their authorized representatives provided written informed consent. The trial was registered at ClinicalTrials.gov ( ).